These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 11912378)
1. Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression. Holmang S; Johansson SL J Urol; 2002 Apr; 167(4):1634-7. PubMed ID: 11912378 [TBL] [Abstract][Full Text] [Related]
2. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year. Guney S; Guney N; Canogullari Z; Ergenekon E Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479 [TBL] [Abstract][Full Text] [Related]
3. Bacillus Calmette-Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression. Andius P; Holmäng S BJU Int; 2004 May; 93(7):980-4. PubMed ID: 15142147 [TBL] [Abstract][Full Text] [Related]
4. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. Herr HW J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743 [TBL] [Abstract][Full Text] [Related]
6. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. Divrik RT; Yildirim U; Zorlu F; Ozen H J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720 [TBL] [Abstract][Full Text] [Related]
7. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors. Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection. Chang WC; Chang YH; Pan CC Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study. Yang TB; Zeng FH; Sun ZQ Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038 [TBL] [Abstract][Full Text] [Related]
11. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer. Kwak C; Ku JH; Park JY; Lee E; Lee SE; Lee C J Urol; 2004 Jan; 171(1):149-52. PubMed ID: 14665864 [TBL] [Abstract][Full Text] [Related]
12. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer. Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171 [TBL] [Abstract][Full Text] [Related]
13. A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database. Mariappan P; Smith G J Urol; 2005 Apr; 173(4):1108-11. PubMed ID: 15758711 [TBL] [Abstract][Full Text] [Related]
14. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. Holmäng S; Hedelin H; Anderström C; Johansson SL J Urol; 1995 Jun; 153(6):1823-6; discussion 1826-7. PubMed ID: 7752327 [TBL] [Abstract][Full Text] [Related]
16. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma. Raman JD; Sosa RE; Vaughan ED; Scherr DS Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658 [TBL] [Abstract][Full Text] [Related]
17. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. Herr HW J Urol; 2000 Jan; 163(1):60-1; discussion 61-2. PubMed ID: 10604314 [TBL] [Abstract][Full Text] [Related]
18. Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer. Cheng CW; Chan SF; Chan LW; Chan CK; Ng CF; Cheung HY; Chan SY; Wong WS; Lai FM; To KF; Li ML Int J Urol; 2005 May; 12(5):449-55. PubMed ID: 15948743 [TBL] [Abstract][Full Text] [Related]
19. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439 [TBL] [Abstract][Full Text] [Related]
20. [Modern follow-up strategies for the treatment of patients with superficial bladder carcinoma]. Werner W; Smesny S; Schubert J Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):519-27. PubMed ID: 10996943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]